Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

NICE issues appraisal consultation documents for three new hepatitis C therapies

Editor's pick
Hepatitis C Trust
30 July 2015
Pharmaceutical industry

Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge

Editor's pick
Bloomberg
30 July 2015
Hepatitis C treatment

Merck Targets Toughest Cases to Gain Hepatitis C Foothold

Editor's pick
Bloomberg
29 July 2015
Hepatitis C treatment

Georgia sets sights on eliminating hepatitis C

Editor's pick
WHO Europe
27 July 2015
Hepatitis C transmission & prevention

Viral hepatitis – 400 deaths a day in the WHO European Region could be prevented

Editor's pick
WHO Europe
27 July 2015
New & experimental hepatitis C treatment

FDA approves Technivie for treatment of chronic hepatitis C genotype 4

Editor's pick
FDA
27 July 2015
Hepatitis C treatment

How Sure Is a Cure?

Editor's pick
Poz
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal Pharmalot blog
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal
19 July 2015
People who inject drugs

Improving access to, and completion of, hepatitis C treatment

Editor's pick
Public Health England
17 July 2015
New & experimental hepatitis C treatment

Gilead pills priced at $1,000 a day are found cost-effective

Editor's pick
Bloomberg
14 July 2015
Hepatitis C treatment

National study finds life-threatening barriers in access to breakthrough drugs

Editor's pick
Eurekalert
30 June 2015
New & experimental hepatitis C treatment

FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data

Editor's pick
Wall Street Journal (blog)
29 June 2015
Hepatitis C treatment

Adding ribavirin to Harvoni for hepatitis C increases side effects but not efficacy

Editor's pick
HIVandHepatitis.com
29 June 2015
Hepatitis C symptoms & diagnosis

Hepatitis C Virus Infection and Alcohol: Challenges and Opportunities

Editor's pick
HCV Action
24 June 2015
Hepatitis C treatment

AbbVie Announces New Phase 3b Results in Genotype 1b Chronic Hepatitis C Patients with Compensated Liver Cirrhosis

Editor's pick
AbbVie press release
24 June 2015
Hepatitis C treatment

Burman's Specialty Pharmacy study shows hepatitis C cure possible while cutting a third of the drug costs

Editor's pick
Burman's Specialty Pharmacy press release
24 June 2015
Access to healthcare

China rejects Gilead hepatitis C drug patent: advocacy group

Editor's pick
Reuters
19 June 2015
Hepatitis C treatment

Hepatitis C: 25 Years Old, and Fading

Editor's pick
Medscape
17 June 2015
Hepatitis C treatment

NHS accused of delaying access to 'highly tolerable' hepatitis C drugs over cost concerns

Editor's pick
The Independent
17 June 2015
Hepatitis C treatment

Prisoners Sue Massachusetts for Withholding Hepatitis C Drugs

Editor's pick
Wall Street Journal (blog)
16 June 2015
Hepatitis C treatment

NHS England announces 'huge investment' for new hepatitis C treatments

Editor's pick
The Pharmaceutical Journal
16 June 2015
Hepatitis C treatment

HCV at a Crossroads:The Pre- or Post-Transplant Treatment Debate

Editor's pick
Healio HCV Next
15 June 2015
Hepatitis C treatment

NHS England stumps up £190m for hep C therapy

Editor's pick
Pharma Times
12 June 2015